Predictors of Treatment Outcome for Smokers With and Without Schizophrenia
- Conditions
- Tobacco Dependence
- Registration Number
- NCT00501007
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Brief Summary
The primary purpose of this investigation is to determine the predictive value of task persistence as measured by a mirror tracing task. A secondary purpose is to evaluate differences in task persistence in smokers with or without schizophrenia. It is hypothesized that task persistence in smokers in both diagnostic categories (schizophrenia and no schizophrenia) will predict tobacco dependence treatment outcome at one and six months. It is also hypothesized that smokers with schizophrenia will show lower levels of task persistence after controlling for other motor skills than smokers without schizophrenia.
- Detailed Description
Please see brief summary above.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 203
- Current smokers must be over the age of 18,
- Must fit into the diagnostic groups schizophrenia / schizoaffective disorder; or the non-schizophrenia group.
- Must smoke at least 10 cigarettes per day
- Must be capable of giving informed consent as measured by Folstein Mini Mental Status Exam of at least 22.
- Those unable to give informed consent.
- Psychotic disorders other than schizophrenia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mirror-tracing Persistence (in Seconds) baseline Number of seconds participants continued working on a mirror tracing task before giving up.
- Secondary Outcome Measures
Name Time Method Persistence as a Prospective Predictor of Smoking Cessation 6 months Analysis of Generalized Estimating Equations (GEE) parameter estimates based on empirical standard error estimates, using an exchangeable working correlation structure, with smoking abstinence as outcome variable, and task persistence, time, diagnosis, ability, Fagerstrom Test for Nicotine Dependence (FTND) score, and the interaction between disorder and persistence as explanatory variables.
Trial Locations
- Locations (1)
UMDNJ Tobacco Dependence Clinic
🇺🇸New Brunswick, New Jersey, United States